in patients with severe peripheral arterial disease. 20 Since then TR PPCI has become popular as a valid alternative to TF PPCI. This changing paradigm is due to patients' comfort, earlier mobilization, shorter hospital stay, reduced bleeding risk, lower cost and possibly survival benefit 7 . There are reports that TR PPCI may have lower radiation exposure in expert hands 21, 22 and may have a mortality advantage. 23, 24, 25 A recent meta analysis on 11 randomized trial involving 9,202 patients compared TR PCI to TF PCI in ACS patients found significantly reduced risk of major bleeding (OR 0.60; 95% CI, 0.41-0.88; p = 0.008), vascular complications (OR 0.35; 95% CI, 0.28-0.46; p<0.001) and reduced the risk of death (OR 0.70; 95% CI = 0.53-0.94, p = 0.016). 26 In STEMI "Time is muscle" meaning that the earlier the reperfusion the more myocardium is salvaged. 27 However, there is concern that TR PPCI may prolong an important quality metric of this procedure which is door-to-balloon (D2B) time, especially with new operator. Society of Cardiovascular Angiography and Intervention (SCAI) 28 has specific recommendation for PPCI. Operators and sites should start performing TR PPCI after performing at least 100 elective PCI cases with a "radial first" approach and their femoral crossover rate should be below 4%. Femoral access for PPCI is recommended if the time to obtain radial access is >3 min, or the time from introducer sheath placement in the radial artery to engaging the infarct related artery with the guide catheter is >10 min.
Ibrahim Cardiac Hospital & Research Institute (ICHRI) started their first TR PCI in the year 2010 and first TR PPCI in 2011. This retrospective study was done to compare the results of TF PPCI versus TR PPCI in our centre.
Methods:
This retrospective study was conducted over a period of 2 years from January 2013 to December 2014. A total of 92 patients based on predefined enrollment criteria were selected out of 108 patients (as some patients' data were incomplete) after taking clearance from ethical review committee. Patients with STEMI attending at Emergency Department of ICHRI within 12 hours of chest pain (between 8 am to 8 pm on each working day according to hospital protocol) and underwent PPCI were included in the study. However patients with shock, advanced renal failure and severe co-morbidities were excluded. The choice of TF or TR access site -right or left and diameter of guide catheter during the procedure were exclusively of operator's choice. Use of thrombus extraction, Intracoronary Glycoprotein IIb/IIIa (IC GPI), Temporary Pacemaker (TPM) depended on the need during the procedure.
The demographic characteristics, risk factors and location of MI on the basis of ECG were recorded. Coronary angiographic findings like single (SVD), double (DVD) or triple vessel disease (TVD) and target coronary vessel of myocardial infarction were noted. Admission time recorded in the hospital database was taken as "door time". Hospital database time corresponds to satellite based standard timing. "Balloon time" was taken from the cath lab station. There was a small difference between cath lab station time with the hospital data base standardized timing. This difference was taken into account while calculating D2B time. Whether drug eluting stent (DES), bare metal stent (BMS) or both types of stent used was also noted. The use of manual thrombus extraction, IC GPI, buddy wire support for stent implantation and peri-procedural TPM were compared between TF and TR groups. Length of hospital stay and in-hospital mortality was also recorded.
Data were processed and analyzed using software SPSS version 11.5. The test statistics used to analyze the data were descriptive statistics, Chi-squared Test (c 2 ), unpaired t-Test, Fisher's Exact Test, The level of significance was set at 0.05 and p <0.05 was considered significant.
Result:
Of the 92 patients who underwent PPCI, 47(51.1%) were approached through TF, 45(48.9%) through TR routes. The mean age of the patients was 53.4±8.9 and 55.0±11.1 years in TF and TR group respectively and the difference was not statistically significant (p =0.430). Majority of the patients were male, only 10.6% female in TF group & 11.1% female in TR group. In the year 2013 PPCI was performed via TF access in 72.3% cases and via TR access in 35.6% cases. In the year 2014 PPCI was performed via TF access in 27.7% cases and via TR access in 64.4% cases indicating a significantly increasing trend of using TR approach in performing PPCI by the operators (Table I) . Table I shows the distribution of risk factors between the groups. There was no significant difference between TF and TR groups with respect to hypertension (40.4% vs. 44.4%, p = 0.697) and diabetes mellitus (31.9% vs. 46.7%, p = 0.147). However, dyslipidaemia demonstrated its significant presence in the latter group (4.3% vs. 8.2%, p = 0.037).
In TF group, 24(48.9%) patients were presented with acute AWMI, 17(36.2%) with acute IWMI, 1(2.2%) with acute IRVWMI & 5(11.1%) with acute IPWMI. In TR group, 20(44.4%) patients were presented with acute AWMI, 23(51.1%) with acute IWMI and 2(4.4%) with acute IPWMI (Table I) .
In TF group, single, double and triple vessel involvements were 21(44.7%), 16(34.0%) & 10(21.3%) respectively, while in the TR group, those were 23(51.1%), 15(33.3%) and 7(15.6%) respectively. There was no statistically significant difference between the groups in terms of number of coronary artery involvement (Table I) Mean hospital stay was almost similar in both groups (4.5±2.4 & 4.7±2.1 days, p =0.883), but mean D2B time was significantly longer in TF group than that in TR group (90.3±37.7 min vs. 79.0±34.6 min, p =0.021) ( Table II) .
Out of 47 patients in TF group, 45 underwent PCI whereas 43 patients underwent PCI in TR group out of 45. Remaining 2 patients in both groups underwent plain old balloon angioplasty (POBA) only. The number stents required in TF group was 55 and that in TR group was 52. Majority of the patients in either group (88.9% in TF and 83.7% in TR group) received DES (p = 0.438). Average stent length & stent diameter were 25.9 ± 12.4 and 2.9 ± 0.4 mm respectively in TF group whereas those were 26.5 ± 8.3 and 2.9 ± 0.5 mm respectively in TR group (Table III) . 35 patients required 1 stent and 10 patients required 2 stents during PPCI in TF group whereas 34 patients required 1 stent and 9 patients required 2 stents during PPCI in TR group. The most commonly used stent diameter in TF group 2.75 mm and that in TR group was 3.0 mm (Table IV) .
IC GPI were used in 14(29.8%) & 11(24.4%) in TF & TR group respectively. Thrombus aspiration was done in 7(14.9%) & 4(8.9%) cases in TF & TR group respectively. TPM was required in 4(8.5%) cases only in TF group. Buddy wiring was required in 1(2.1%) & 4(8.9%) cases in TF & TR group respectively. The incidence of angiographic no reflow was seen in 2(4.3%) patients only in TF group. One patient died in each group after the procedure related to ventilator associated pneumonia (Table V) . 
Discussion:
This single-center retrospective study revealed several important findings. First, the use of TR approach is increasingly becoming popular among our intervention cardiologists, which corresponds well with a worldwide trend in the use of TR. Secondly, there were no observed differences in mortality TF and TR PCI. Finally, the doorto-balloon time was significantly decreased with TR which has important implications for future clinical practice.
Two frequently cited randomized trials, The RadIal Vs femorAL access for coronary intervention (RIVAL) and RadIal versus FemoraL randomizEd investigation in STElevation Acute Coronary Syndrome (RIFLE-STEACS), showed a mortality benefit for TR in patients with STEMI. 11, 12 The mortality benefit is thought to be due to reduction in bleeding events, as it is known that post-PCI bleeding is independently related to mortality in ACS. 29, 30 Although our current study did not show a mortality benefit in TR over TF, it was likely underpowered to show a mortality benefit due to low absolute number of total deaths (1 death in each group). This may have been due to selection of relatively healthy patients and excluding those in shock or renal failure.
When it was first introduced, TR PCI was rarely used in clinical practice. This may have been due to concerns about the difficulty with radial access, navigation of the tortuous arm vasculature to engage the coronary arteries, and inability to use larger thrombectomy catheters. However, given the benefit in mortality and/or bleeding seen on recent studies, there has been increasing adoption of the TR approach globally in recent years and subsequently there has been increasing expertise in this technique. 31, 32 This increasing trend in using TR is reflected in our data, which shows a 28.8% absolute increase in the use of TR from 2013 to 2014, which was found to be statistically significant. The changing trend is largely driven by the increasing comfort on the part of the operator.
Despite the growing body of evidence for mortality benefit with TR in STEMI, there have been questions raised regarding whether D2B is delayed in TR. This is a valid concern as D2B time is a well-known parameter for better outcomes and shortened D2B times have been linked to improved survival. 33 In the context of above mentioned data, the reduction in D2B time in our study could be considered a significant finding. This is most likely due to the growing operator experience with TR PCI at our institution since 2011, as mentioned earlier that successful TR PCI is largely dependent on operator experience. Procedural time has been shown to decrease with higher volume 15 and low TR volume has been associated with both worse clinical outcomes and access site failure requiring crossover. 11,36 Additionally, our finding of decreased D2B time was independent of the complexity of the procedure, as there were no statistically significant differences in stent dimensions and number of stents between TR and TF groups.
However, we encountered several limitations which deserve mention. As with any retrospective observational study, it was difficult to adjust for all confounding factors that might have affected D2B time and length of hospital stay. Therefore they may have been hidden factors that may have biased the results in favor of the radial access. Another limitation is the fact that the operators in our trial were skilled in the TR approach and performed a larger volume over the two-year study period. This may not be the case in other centers where operators mainly perform TF approach. Therefore the external validity of this study is limited.
Conclusion:
Our single center retrospective analysis showed a decrease in the D2B time with TR PCI, which makes it an attractive option for PCI in STEMI. Despite the growing evidence for benefit in mortality and bleeding with TR PCI, it continued to be less commonly used in clinical practice.
As outcomes with TR PCI are largely dependent on experience, centers and individual operators should continue to develop expertise in the use of the radial technique, and should do so by following the recommended guidelines from SCAI.
